Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,693 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,751
Recruiting: 1,518
Ph III recruiting: 166
Growth YoY: +8.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,317)

clinicaltrialsPublishedShowing 3,951–3,983 of 3,983 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00165217	Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma	completed	Phase 2	37	Dana-Farber Cancer InstituteOTHER	1	Dec 21, 2007	clinicaltrials
NCT00464295	Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)(HCC-CAP)	completed	Phase 2	15	Aga Khan UniversityOTHER	1	Dec 14, 2007